OMX Nordic 40
2.328,27
PKT
-25,23
PKT
-1,07
%
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 20.09.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 19.09.24 | Nokia Underweight | Barclays Capital | |
| 18.09.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 18.09.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 18.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 17.09.24 | Nokia Neutral | Goldman Sachs Group Inc. | |
| 17.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 16.09.24 | AstraZeneca Sell | UBS AG | |
| 13.09.24 | AstraZeneca Sell | Deutsche Bank AG | |
| 12.09.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 11.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 11.09.24 | Novo Nordisk Neutral | UBS AG | |
| 11.09.24 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 10.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.09.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 10.09.24 | A.P. Moeller - Maersk A-S (B) Underweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Sell | UBS AG | |
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 06.09.24 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 05.09.24 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 05.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.09.24 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 03.09.24 | Volvo (B) Sector Perform | RBC Capital Markets | |
| 03.09.24 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 03.09.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.08.24 | Hennes Mauritz (H M, H&M) Overweight | Barclays Capital | |
| 28.08.24 | Hennes Mauritz (H M, H&M) Sell | Goldman Sachs Group Inc. | |
| 28.08.24 | Hennes Mauritz (H M, H&M) Hold | Jefferies & Company Inc. | |
| 28.08.24 | Novo Nordisk Buy | Deutsche Bank AG | |
| 28.08.24 | Hennes Mauritz (H M, H&M) Underweight | JP Morgan Chase & Co. | |
| 27.08.24 | Hennes Mauritz (H M, H&M) Outperform | RBC Capital Markets | |
| 27.08.24 | Volvo (B) Buy | Goldman Sachs Group Inc. | |
| 15.08.24 | AstraZeneca Sell | UBS AG | |
| 15.08.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 14.08.24 | Volvo (B) Buy | Jefferies & Company Inc. | |
| 13.08.24 | AstraZeneca Sell | UBS AG | |
| 13.08.24 | Hennes Mauritz (H M, H&M) Buy | Deutsche Bank AG | |
| 09.08.24 | Novo Nordisk Neutral | UBS AG | |
| 08.08.24 | Novo Nordisk Buy | Goldman Sachs Group Inc. |